Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 26, 2014 - Issue 2
522
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Urban air pollution and effects on biomarkers of systemic inflammation and coagulation: a panel study in healthy adults

, , , &
Pages 84-94 | Received 31 Oct 2012, Accepted 15 Oct 2013, Published online: 04 Feb 2014

References

  • Aso Y. (2007). Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci 12:2957–66
  • Barclay JL, Miller BG, Dick S, et al. (2009). A panel study of air pollution in subjects with heart failure: negative results in treated patients. Occup Environ Med 66:325–34
  • Barregard L, Saellsten G, Andersson L, et al. (2008). Experimental exposure to wood smoke: effects on airway inflammation and oxidative stress. Occup Environ Med 65:319–24
  • Brook RD, Franklin B, Cascio W, et al. (2004). Air pollution and cardiovascular disease – a statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association. Circulation 109:2655–71
  • Brook RD, Rajagopalan S, Pope CA, et al. (2010). Particulate matter air pollution and cardiovascular disease an update to the scientific statement from the American Heart Association. Circulation 121:2331–78
  • Chuang KJ, Chan CC, Su TC, et al. (2007). The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med 176:370–6
  • Danesh J, Lewington S, Thompson SG, et al. (2005). Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality – an individual participant meta-analysis. JAMA 294:1799–809
  • Delfino RJ, Staimer N, Tjoa T, et al. (2008). Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 116:898–906
  • Ebelt ST, Petkau AJ, Vedal S, et al. (2000). Exposure of chronic obstructive pulmonary disease patients to particulate matter: relationships between personal and ambient air concentrations. J Air Waste Manag Assoc 50:1081–94
  • Elangbam CS, Qualls CW, Dahlgren RR. (1997). Cell adhesion molecules – update. Vet Pathol 34:61–73
  • Gabay C, Kushner I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–54
  • Ghio AJ, Huang YCT. (2004). Exposure to concentrated ambient particles (CAPs): a review. Inhal Toxicol 16:53–9
  • Haverslag R, Pasterkamp G, Hoefer IE. (2008). Targeting adhesion molecules in cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets 8:252–60
  • Hermans C, Bernard A. (1999). Lung epithelium-specific proteins – characteristics and potential applications as markers. Am J Respir Crit Care Med 159:646–78
  • Hildebrandt K, Ruckerl R, Koenig W, et al. (2009). Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease. Part Fibre Toxicol 6:25
  • Hornung RW, Reed LD. (1990). Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5:46–51
  • Huo Y, Ley K. (2001). Adhesion molecules and atherogenesis. Acta Physiol Scand 173:35–43
  • Huttunen K, Siponen T, Salonen I, et al. (2012). Low-level exposure to ambient particulate matter is associated with systemic inflammation in ischemic heart disease patients. Environ Res 116:44–51
  • Janssen NAH, De Hartog JJ, Hoek G, et al. (2000). Personal exposure to fine particulate matter in elderly subjects: relation between personal, indoor, and outdoor concentrations. J Air Waste Manag Assoc 50:1133–43
  • Janssen NAH, Lanki T, Hoek G, et al. (2005). Associations between ambient, personal and indoor exposure to fine particulate matter constituents in Dutch and Finnish panels of cardiovascular patients. Occup Environ Med 62:868–77
  • Johannesson S, Gustafson P, Molnár P, et al. (2007). Exposure to fine particles (PM2.5 and PM1) and black smoke in the general population: personal, indoor, and outdoor levels. J Expo Sci Environ Epidemiol 17:613–24
  • Juhanvague I, Pyke SDM, Alessi MC, et al. (1996). Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 94:2057–63
  • Kaptoge S, Di Angelantonio E, Lowe G, et al. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132–40
  • Li Y, Rittenhouse-Olson K, Scheider WL, Mu L. (2012). Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies. Rev Environ Health 27:133–49
  • Liao DP, Heiss G, Chinchilli VM, et al. (2005). Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study. J Expo Anal Environ Epidemiol 15:319–28
  • Mustafic H, Jabre P, Caussin C, et al. (2012). Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA 307:713–21
  • O'Toole TE, Hellmann J, Wheat L, et al. (2010). Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circ Res 107:200–3
  • Pai JK, Pischon T, Jing M, et al. (2004). Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599–610
  • Panasevich S, Leander K, Rosenlund M, et al. (2009). Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med 66:747–53
  • Pearson TA, Mensah GA, Alexander RW, et al. (2003). Markers of inflammation and cardiovascular disease application to clinical and public health practice – a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 107:499–511
  • Pope CA, Hansen ML, Long RW, et al. (2004). Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects. Environ Health Perspect 112:339–45
  • Rappaport SM, Kupper LL. (2008). Qantitative Exposure Assessment. El Cerrito, CA, USA: Stephen Rappaport
  • Rich DQ, Kipen HM, Huang W, et al. (2012). Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults. JAMA 307:2068–78
  • Ruckerl R, Greven S, Ljungman P, et al. (2007). Air pollution and inflammation (IL-6, fibrinogen, CRP) in myocardial infarction survivors. Environ Health Perspect 115:1072–80
  • Ruckerl R, Ibald-Mulli A, Koenig W, et al. (2006). Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 173:432–41
  • Ruckerl R, Schneider A, Breitner S, et al. (2011). Health effects of particulate air pollution: a review of epidemiological evidence. Inhal Toxicol 23:555–92
  • Rudez G, Janssen NAH, Kilinc E, et al. (2009). Effects of ambient air pollution on hemostasis and inflammation. Environ Health Perspect 117:995–1001
  • Sacks JD, Stanek LW, Luben TJ, et al. (2011). Particulate matter-induced health effects: who is susceptible? Environ Health Perspect 119:446–54
  • Schäuble CL, Hampel R, Breitner S, et al. (2012). Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals. Occup Environ Med 69:670–8
  • Seaton A, Soutar A, Crawford V, et al. (1999). Particulate air pollution and the blood. Thorax 54:1027–32
  • Stockfelt L, Sallsten G, Olin AC, et al. (2012). Effects on airways of short-term exposure to two kinds of wood smoke in a chamber study of healthy humans. Inhal Toxicol 24:47–59
  • Sullivan JH, Hubbard R, Liu SLJ, et al. (2007). A community study of the effect of particulate matter on blood measures of inflammation and thrombosis in an elderly population. Environ Health 6:3
  • WHO. (2005). WHO air quality guidelines global update 2005. EUR/05/5046029. Copenhagen, Denmark: World Health Organization, Regional Office for Europe

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.